ArticlebioRxiv : the preprint server for biology2025

In vivo CRISPR screening links NFKB1 to endocrine resistance in ER⁺ breast cancer.

Cancan Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.